Showing results (1051-1060 of 26,311) with videos related to
Sort By:
Pageof 2,632
Bioorganic & Medicinal Chemistry Letters|March 10, 2021
Functional amyloids in the human bodyAmy Brown, Marianna TörökBioorganic & Medicinal Chemistry Letters|March 8, 2021
In vitro antifungal activities, molecular docking, and DFT studies of 4-amine-3-hydrazino-5-mercapto-1,2,4-triazole derivativesLe Qi, Mou-Cui Li, Jia-Chao Bai, et al.Bioorganic & Medicinal Chemistry Letters|March 8, 2021
Free energy perturbation in the design of EED ligands as inhibitors of polycomb repressive complex 2 (PRC2) methyltransferaseDaniel H O' Donovan, Clare Gregson, Martin J Packer, et al.Bioorganic & Medicinal Chemistry Letters|March 8, 2021
Novel monocyclic amide-linked phenol derivatives without mitochondrial toxicity have potent uric acid-lowering activityJunichiro Uda, Seiichi Kobashi, Naoki Ashizawa, et al.Bioorganic & Medicinal Chemistry Letters|September 11, 2022
Discovery of MDV6058 (PF-06952229), a selective and potent TGFβR1 inhibitor: Design, synthesis and optimizationBrahmam Pujala, Sreekanth A Ramachandran, Mukesh Sonawane, et al.Bioorganic & Medicinal Chemistry Letters|September 11, 2022
Efficient synthesis and evaluation of novel 6-arylamino-[1,2,4]triazolo[4,3-a]pyridine derivatives as antiproliferative agentsMan-Yu Lin, Tang-Yang Ji, Miao Zheng, et al.Bioorganic & Medicinal Chemistry Letters|November 5, 2021
Synthesis and antiviral evaluation of cytisine derivatives against dengue virus types 1 and 2Inna P Tsypysheva, Hsueh-Chou Lai, Yan-Tung Kiu, et al.Bioorganic & Medicinal Chemistry Letters|January 10, 2022
Effect of removal of the 14-hydroxy group on the affinity of the 4,5-epoxymorphinan derivatives for orexin and opioid receptorsKoki Katoh, Naoshi Yamamoto, Yukiko Ishikawa, et al.Bioorganic & Medicinal Chemistry Letters|January 10, 2022
Novel 2,4-disubstituted quinazoline analogs as antibacterial agents with improved cytotoxicity profile: Modification of the benzenoid partSarah H Megahed, Sari Rasheed, Jennifer Herrmann, et al.Bioorganic & Medicinal Chemistry Letters|January 10, 2022
Novel benzothiazole-based dual VEGFR-2/EGFR inhibitors targeting breast and liver cancers: Synthesis, cytotoxic activity, QSAR and molecular docking studiesEman A Abd El-Meguid, Ahmed M Naglah, Gaber O Moustafa, et al.Pageof 2,632